Drug Shortage Report for INDERAL-LA

Last updated on 2022-02-24 History
Report ID 155253
Drug Identification Number 02042258
Brand name INDERAL-LA
Common or Proper name INDERAL LA
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) PROPRANOLOL HYDROCHLORIDE
Strength(s) 80MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100's
ATC code C07AA
ATC description BETA BLOCKING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-02-21
Actual start date 2022-02-21
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-02-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2022-02-24 French Compare
v6 2022-02-24 English Compare
v5 2022-02-22 French Compare
v4 2022-02-22 English Compare
v3 2022-02-22 English Compare
v2 2022-02-17 French Compare
v1 2022-02-17 English Compare

Showing 1 to 7 of 7